Related topics: Preclinical Research
Galapagos has slashed the price it is paying for Inpharmatica by a third after the latter failed to reach a milestone built in to the sale negotiations.
Copyright - Unless otherwise stated all contents of this web site are © 2012 - William Reed Business Media SAS - All Rights Reserved - Full details for the use of materials on this site can be found in the Terms & Conditions